# Spanish Series of Patients Treated With the Radionuclide Lutetium177

> **NCT04949282** · — · RECRUITING · sponsor: **Sociedad Española de Medicina Nuclear e Imagen Molecular** · enrollment: 5000 (estimated)

## Conditions studied

- Neuroendocrine Tumors
- Intestinal Neoplasms
- Pancreatic Neoplasms
- Stomach Neoplasms
- Neuroectodermal Tumors
- Neoplasms, Germ Cell and Embryonal
- Neoplasms by Histologic Type
- Neoplasms
- Neoplasms, Nerve Tissue
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Neoplasms by Site
- Endocrine Gland Neoplasms
- Digestive System Diseases
- Gastrointestinal Disease
- Intestinal Diseases
- Pancreatic Disease
- Endocrine System Diseases

## Interventions

- **DRUG:** Lutetium [177Lu] oxodotreotide/dotatate
- **DEVICE:** Lutetium [177Lu] oxodotreotide/dotatate

## Key facts

- **NCT ID:** NCT04949282
- **Lead sponsor:** Sociedad Española de Medicina Nuclear e Imagen Molecular
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-05-10
- **Primary completion:** 2034-12-31
- **Final completion:** 2035-12-31
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2022-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04949282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04949282, "Spanish Series of Patients Treated With the Radionuclide Lutetium177". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04949282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*